Paroxetine effects on morphine analgesic tolerance in rats
Author:
Sahebi Vaighan Navideh1, Parhiz Soha1, Sabetkasaei Masoumeh1, Moini Zanjani Taraneh1, Zarei Malek1
Affiliation:
1. Department of Pharmacology, Faculty of Medicine , Shahid Beheshti University of Medical Sciences , Tehran , Iran
Abstract
Abstract
Objectives
To alleviate different pain intensities, morphine administration has been extensively used. However, prolonged administration of morphine leads to a progressive decline of its analgesic effect which limits their overall utility. Morphine tolerance is considered as a challenging issue for the treatment of both acute and chronic pain. We conducted this study in rats to investigate the effect of paroxetine on morphine tolerance when used preemptively or after morphine tolerance had developed.
Methods
Male Wistar rats (weight 250–300 g, n=10) were used to evaluate the effects of paroxetine on tolerance to morphine. In order to induce tolerance, daily intraperitoneal injection of morphine (7 mg/kg) was done. After tolerance induction, a group of animals received intraperitoneal injection of 10 mg/kg paroxetine 30 min prior to each morphine dose. In another trial, to investigate the potential of paroxetine to prevent tolerance to morphine, animals were pretreated with 10 mg/kg paroxetine 30 min before morphine administration. In the control groups, 10 mL/kg of saline was injected. The behavioral test (tail-flick test) was done for all groups.
Results
Our data showed that paroxetine significantly reversed tolerance to morphine when used after tolerance induction (p<0.001). However, administration of paroxetine before occurrence of tolerance had no effect.
Conclusions
We conclude that paroxetine could decrease tolerance to morphine when used after the occurrence of morphine tolerance, while it was not able to prevent morphine tolerance when administered preemptively.
Ethical committee number
IRIB.SBMU.MSP.REC.1394.098.
Publisher
Walter de Gruyter GmbH
Subject
Anesthesiology and Pain Medicine,Neurology (clinical)
Reference43 articles.
1. Merskey, HE. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Pain 1986;3(Supp):S1–225. 2. Vos, T, Allen, C, Arora, M, Barber, RM, Bhutta, ZA, Brown, A, et al.. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1545–602. https://doi.org/10.1016/S0140-6736(16)31678-6. 3. Berry, PH, Chapman, CR, Covington, EC, Dahl, JL, Katz, JA, Miaskowski, C, et al.. Pain: current understanding of assessment, management, and treatments. Natl Pharm Counc Jt Comm Accredit Health Organ VA, USA 2001:b44. 4. Rosenblum, A, Marsch, LA, Joseph, H, Portenoy, RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16:405–16. https://doi.org/10.1037/a0013628. 5. Eisenstein, TK. The role of opioid receptors in immune system function. Front Immunol 2019;10:2904. https://doi.org/10.3389/fimmu.2019.02904.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|